Go Pro

Oaktree Acquisition Corp. III Life Sciences (OACC) Competitors

Oaktree Acquisition Corp. III Life Sciences logo
$10.72 +0.02 (+0.23%)
As of 04:00 PM Eastern
This is a fair market value price provided by Massive. Learn more.

OACC vs. FAC, ABR, ESRT, CSR, and KDK

Should you buy Oaktree Acquisition Corp. III Life Sciences stock or one of its competitors? MarketBeat compares Oaktree Acquisition Corp. III Life Sciences with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Oaktree Acquisition Corp. III Life Sciences include Factorial Energy (FAC), Arbor Realty Trust (ABR), Empire State Realty Trust (ESRT), Centerspace (CSR), and Kodiak AI (KDK). These companies are all part of the "trading" industry.

How does Oaktree Acquisition Corp. III Life Sciences compare to Factorial Energy?

Factorial Energy (NASDAQ:FAC) and Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) are both small-cap financial services companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, risk, profitability, valuation, earnings and dividends.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Factorial EnergyN/AN/A$6.22M$0.2421.75
Oaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/A

Oaktree Acquisition Corp. III Life Sciences' return on equity of 0.00% beat Factorial Energy's return on equity.

Company Net Margins Return on Equity Return on Assets
Factorial EnergyN/A -60.51% 2.80%
Oaktree Acquisition Corp. III Life Sciences N/A N/A N/A

Factorial Energy presently has a consensus price target of $18.00, indicating a potential upside of 244.83%. Given Factorial Energy's stronger consensus rating and higher probable upside, equities research analysts plainly believe Factorial Energy is more favorable than Oaktree Acquisition Corp. III Life Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Factorial Energy
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
Oaktree Acquisition Corp. III Life Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, Factorial Energy had 5 more articles in the media than Oaktree Acquisition Corp. III Life Sciences. MarketBeat recorded 6 mentions for Factorial Energy and 1 mentions for Oaktree Acquisition Corp. III Life Sciences. Oaktree Acquisition Corp. III Life Sciences' average media sentiment score of 1.82 beat Factorial Energy's score of 0.81 indicating that Oaktree Acquisition Corp. III Life Sciences is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Factorial Energy
2 Very Positive mention(s)
4 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Oaktree Acquisition Corp. III Life Sciences
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Summary

Factorial Energy beats Oaktree Acquisition Corp. III Life Sciences on 5 of the 7 factors compared between the two stocks.

How does Oaktree Acquisition Corp. III Life Sciences compare to Arbor Realty Trust?

Arbor Realty Trust (NYSE:ABR) and Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) are both small-cap trading companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, dividends, valuation, earnings, profitability and analyst recommendations.

57.3% of Arbor Realty Trust shares are held by institutional investors. 4.2% of Arbor Realty Trust shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Arbor Realty Trust currently has a consensus target price of $6.50, suggesting a potential upside of 29.61%. Given Arbor Realty Trust's stronger consensus rating and higher probable upside, equities analysts plainly believe Arbor Realty Trust is more favorable than Oaktree Acquisition Corp. III Life Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Arbor Realty Trust
4 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.50
Oaktree Acquisition Corp. III Life Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Arbor Realty Trust has a net margin of 12.73% compared to Oaktree Acquisition Corp. III Life Sciences' net margin of 0.00%. Arbor Realty Trust's return on equity of 8.49% beat Oaktree Acquisition Corp. III Life Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Arbor Realty Trust12.73% 8.49% 1.46%
Oaktree Acquisition Corp. III Life Sciences N/A N/A N/A

Arbor Realty Trust has a beta of 1.15, suggesting that its share price is 15% more volatile than the broader market. Comparatively, Oaktree Acquisition Corp. III Life Sciences has a beta of -0.01, suggesting that its share price is 101% less volatile than the broader market.

In the previous week, Arbor Realty Trust had 7 more articles in the media than Oaktree Acquisition Corp. III Life Sciences. MarketBeat recorded 8 mentions for Arbor Realty Trust and 1 mentions for Oaktree Acquisition Corp. III Life Sciences. Oaktree Acquisition Corp. III Life Sciences' average media sentiment score of 1.82 beat Arbor Realty Trust's score of 1.19 indicating that Oaktree Acquisition Corp. III Life Sciences is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Arbor Realty Trust
6 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Oaktree Acquisition Corp. III Life Sciences
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Arbor Realty Trust has higher revenue and earnings than Oaktree Acquisition Corp. III Life Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Arbor Realty Trust$940.01M1.03$148.80M$0.3912.86
Oaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/A

Summary

Arbor Realty Trust beats Oaktree Acquisition Corp. III Life Sciences on 11 of the 12 factors compared between the two stocks.

How does Oaktree Acquisition Corp. III Life Sciences compare to Empire State Realty Trust?

Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) and Empire State Realty Trust (NYSE:ESRT) are both small-cap trading companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, valuation, earnings, profitability, media sentiment and analyst recommendations.

Empire State Realty Trust has a consensus target price of $5.92, indicating a potential upside of 5.94%. Given Empire State Realty Trust's stronger consensus rating and higher possible upside, analysts plainly believe Empire State Realty Trust is more favorable than Oaktree Acquisition Corp. III Life Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oaktree Acquisition Corp. III Life Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Empire State Realty Trust
2 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.33

67.1% of Empire State Realty Trust shares are owned by institutional investors. 15.2% of Empire State Realty Trust shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Oaktree Acquisition Corp. III Life Sciences has a beta of -0.01, indicating that its share price is 101% less volatile than the broader market. Comparatively, Empire State Realty Trust has a beta of 1.35, indicating that its share price is 35% more volatile than the broader market.

Empire State Realty Trust has a net margin of 5.09% compared to Oaktree Acquisition Corp. III Life Sciences' net margin of 0.00%. Empire State Realty Trust's return on equity of 2.19% beat Oaktree Acquisition Corp. III Life Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Oaktree Acquisition Corp. III Life SciencesN/A N/A N/A
Empire State Realty Trust 5.09%2.19%0.93%

In the previous week, Empire State Realty Trust had 3 more articles in the media than Oaktree Acquisition Corp. III Life Sciences. MarketBeat recorded 4 mentions for Empire State Realty Trust and 1 mentions for Oaktree Acquisition Corp. III Life Sciences. Oaktree Acquisition Corp. III Life Sciences' average media sentiment score of 1.82 beat Empire State Realty Trust's score of 0.48 indicating that Oaktree Acquisition Corp. III Life Sciences is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Oaktree Acquisition Corp. III Life Sciences
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Empire State Realty Trust
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Empire State Realty Trust has higher revenue and earnings than Oaktree Acquisition Corp. III Life Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/A
Empire State Realty Trust$768.27M1.25$47.60M$0.2621.48

Summary

Empire State Realty Trust beats Oaktree Acquisition Corp. III Life Sciences on 10 of the 11 factors compared between the two stocks.

How does Oaktree Acquisition Corp. III Life Sciences compare to Centerspace?

Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) and Centerspace (NYSE:CSR) are both small-cap trading companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, profitability, risk, valuation, earnings, analyst recommendations and media sentiment.

In the previous week, Centerspace had 2 more articles in the media than Oaktree Acquisition Corp. III Life Sciences. MarketBeat recorded 3 mentions for Centerspace and 1 mentions for Oaktree Acquisition Corp. III Life Sciences. Oaktree Acquisition Corp. III Life Sciences' average media sentiment score of 1.82 beat Centerspace's score of 0.75 indicating that Oaktree Acquisition Corp. III Life Sciences is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Oaktree Acquisition Corp. III Life Sciences
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Centerspace
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Centerspace has a net margin of 2.93% compared to Oaktree Acquisition Corp. III Life Sciences' net margin of 0.00%. Centerspace's return on equity of 0.94% beat Oaktree Acquisition Corp. III Life Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Oaktree Acquisition Corp. III Life SciencesN/A N/A N/A
Centerspace 2.93%0.94%0.40%

Centerspace has higher revenue and earnings than Oaktree Acquisition Corp. III Life Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/A
Centerspace$273.66M3.43$17.59M$0.45124.24

Oaktree Acquisition Corp. III Life Sciences has a beta of -0.01, meaning that its share price is 101% less volatile than the broader market. Comparatively, Centerspace has a beta of 0.89, meaning that its share price is 11% less volatile than the broader market.

Centerspace has a consensus price target of $68.80, indicating a potential upside of 23.06%. Given Centerspace's stronger consensus rating and higher possible upside, analysts plainly believe Centerspace is more favorable than Oaktree Acquisition Corp. III Life Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oaktree Acquisition Corp. III Life Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Centerspace
0 Sell rating(s)
6 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25

79.0% of Centerspace shares are owned by institutional investors. 0.5% of Centerspace shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Centerspace beats Oaktree Acquisition Corp. III Life Sciences on 11 of the 12 factors compared between the two stocks.

How does Oaktree Acquisition Corp. III Life Sciences compare to Kodiak AI?

Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) and Kodiak AI (NASDAQ:KDK) are both small-cap financial services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, media sentiment, risk and analyst recommendations.

72.9% of Kodiak AI shares are held by institutional investors. 28.4% of Kodiak AI shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Oaktree Acquisition Corp. III Life Sciences has higher earnings, but lower revenue than Kodiak AI.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/A
Kodiak AI$4.16M189.78-$585.53M-$0.91N/A

Kodiak AI has a consensus target price of $12.50, indicating a potential upside of 191.38%. Given Kodiak AI's stronger consensus rating and higher probable upside, analysts clearly believe Kodiak AI is more favorable than Oaktree Acquisition Corp. III Life Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oaktree Acquisition Corp. III Life Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Kodiak AI
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.75

Oaktree Acquisition Corp. III Life Sciences has a beta of -0.01, suggesting that its share price is 101% less volatile than the broader market. Comparatively, Kodiak AI has a beta of 0.4, suggesting that its share price is 60% less volatile than the broader market.

In the previous week, Kodiak AI had 6 more articles in the media than Oaktree Acquisition Corp. III Life Sciences. MarketBeat recorded 7 mentions for Kodiak AI and 1 mentions for Oaktree Acquisition Corp. III Life Sciences. Oaktree Acquisition Corp. III Life Sciences' average media sentiment score of 1.82 beat Kodiak AI's score of 0.39 indicating that Oaktree Acquisition Corp. III Life Sciences is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Oaktree Acquisition Corp. III Life Sciences
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Kodiak AI
1 Very Positive mention(s)
3 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral

Company Net Margins Return on Equity Return on Assets
Oaktree Acquisition Corp. III Life SciencesN/A N/A N/A
Kodiak AI N/A N/A -42.57%

Summary

Kodiak AI beats Oaktree Acquisition Corp. III Life Sciences on 9 of the 11 factors compared between the two stocks.

Get Oaktree Acquisition Corp. III Life Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for OACC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OACC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OACC vs. The Competition

MetricOaktree Acquisition Corp. III Life SciencesInvestment Offices IndustryFinancial SectorNASDAQ Exchange
Market Cap$263.04M$293.49M$6.10B$12.28B
Dividend YieldN/AN/A5.24%9.39%
P/E RatioN/A2.0829.5223.94
Price / SalesN/A146.351,201.2791.95
Price / CashN/A135.1488.7447.25
Price / BookN/A353.266.666.14
Net IncomeN/A-$66.54M$1.13B$331.74M
7 Day Performance-0.08%-0.46%-0.16%-1.72%
1 Month PerformanceN/A-0.55%-0.17%-1.44%
1 Year Performance2.68%2.80%14.62%16.97%

Oaktree Acquisition Corp. III Life Sciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OACC
Oaktree Acquisition Corp. III Life Sciences
N/A$10.71
+0.1%
N/A+2.6%$263.04MN/AN/AN/A
FAC
Factorial Energy
3.1552 of 5 stars
$9.32
flat
$18.00
+93.1%
N/A$997.43MN/A38.832
ABR
Arbor Realty Trust
4.7548 of 5 stars
$5.06
+0.1%
$7.38
+45.9%
-53.9%$972.38M$940.01M12.96630
ESRT
Empire State Realty Trust
2.0581 of 5 stars
$5.43
-0.1%
$5.92
+9.1%
-24.2%$935.43M$768.27M20.87670
CSR
Centerspace
4.5662 of 5 stars
$55.57
flat
$68.80
+23.8%
-5.3%$933.74M$271.64M123.49470

Related Companies and Tools


This page (NASDAQ:OACC) was last updated on 7/20/2026 by MarketBeat.com Staff.
From Our Partners